Dominant-Negative Tumor Necrosis Factor Protects from Mycobacterium bovis Bacillus Calmette-Guérin (BCG) and Endotoxin-Induced Liver Injury without Compromising Host Immunity to BCG and Mycobacterium tuberculosis

Olleros, Maria L.; Vesin, Dominique; Lambou, Agathe F.; Janssens, Jean-Paul; Ryffel, Bernhard; Rose, Stéphanie; Frémond, Cécile; Quesniaux, Valérie F.; Szymkowski, David E.; Garcia, Irene
April 2009
Journal of Infectious Diseases;4/1/2009, Vol. 199 Issue 7, p1053
Academic Journal
Background. Tumor necrosis factor (TNF) is associated with the development of inflammatory pathologies. Antibodies and soluble TNF (solTNF) receptors that neutralize excessive TNF are effective therapies for inflammatory and autoimmune diseases. However, clinical use of TNF inhibitors is associated with an increased risk of infections. Methods. A novel dominant-negative (DN) strategy of selective TNF neutralization, consisting of blocking solTNF while sparing transmembrane TNF (tmTNF), was tested in mouse models of mycobacterial infection and acute liver inflammation. XENP1595, a DN-TNF biologic, was compared with etanercept, a TNF receptor 2 (TNFR2)-IgG1 Fc fusion protein that inhibits murine solTNF and tmTNF. Results. XENP1595 protected mice from acute liver inflammation induced by endotoxin challenge in Mycobacterium bovis bacillus Calmette-Guérin (BCG)-infected mice, but, in contrast to etanercept, it did not compromise host immunity to acute M. bovis BCG and Mycobacterium tuberculosis infections in terms of bacterial burden, granuloma formation, and innate immune responses. Conclusions. A selective inhibitor of solTNF efficiently protected mice from acute liver inflammation yet maintained immunity to mycobacterial infections. In contrast, nonselective inhibition of solTNF and tmTNF suppressed immunity to M. bovis BCG and M. tuberculosis. Therefore, selective inhibition of solTNF by DN-TNF biologics may represent a new therapeutic strategy for the treatment of inflammatory diseases without compromising host immunity.


Related Articles

  • Tumor Necrosis Factor-Alpha Induced by Hepatitis B Virus Core Mediating the Immune Response for Hepatitis B Viral Clearance in Mice Model. Tzeng, Horng-Tay; Tsai, Hwei-Fang; Chyuan, I-Tsu; Liao, Hsiu-Jung; Chen, Chun-Jen; Chen, Pei-Jer; Hsu, Ping-Ning // PLoS ONE;Jul2014, Vol. 9 Issue 7, p1 

    Persistent hepatitis B viral (HBV) infection results in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC). An efficient control of virus infections requires the coordinated actions of both innate and adaptive immune responses. In order to define the role of innate immunity...

  • TNF-α: A Paradigm of Paradox and Complexity in Multiple Sclerosis and its Animal Models. Su-Yin Lim; Constantinescu, Cris S. // Open Autoimmunity Journal;2010 Special Issue 3, p160 

    TNF-α (tumour necrosis factor-) is a pleiotropic cytokine with wide-ranging actions on the immune system and is an important mediator in immune-mediated inflammatory disease states, including multiple sclerosis. TNF-α and its receptors are part of a large and complex superfamily of...

  • Attenuated EAN in TNF-α Deficient Mice Is Associated with an Altered Balance of M1/M2 Macrophages. Zhang, Hong-Liang; Hassan, Mohammed Y.; Xiang-Yu Zheng; Azimullah, Sheikh; Quezada, Hernan Concha; Amir, Naheed; Elwasila, Mohamed; Mix, Eilhard; Adem, Abdu; Jie Zhu // PLoS ONE;May2012, Vol. 7 Issue 5, p1 

    The role of tumor necrosis factor (TNF)-α and its receptors in neuroautoimmune and neuroinflammatory diseases has been controversial. On the basis of our previous studies, we hereby aimed to further clarify TNF-α's mechanism of action and to explore the potential role of TNF-α receptor...

  • Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease. Sun, Yonglian; Chen, Helen M.; Subudhi, Sumit K.; Chen, Jonathan; Koka, Rima; Chen, Lieping; Fu, Yang-Xin // Nature Medicine;Dec2002, Vol. 8 Issue 12, p1405 

    Humans and mice deficient in Fas, a tumor necrosis factor (TNF)-receptor family member, cannot induce apoptosis of autoreactive cells, and consequently develop progressive lymphoproliferative disorders and lupus-like autoimmune diseases. Previous studies have shown that short-term...

  • Moving closer to a mouse model for hepatitis C.  // Nature Medicine;Mar2009, Vol. 15 Issue 3, p251 

    The article provides authors' insights on a mouse model for treating hepatitis C virus (HCV). It notes that to study immune responses and develop vaccines are laborious and unsuitable despite the usefulness of the models. Furthermore, HCV replication is inefficient in mouse cells, although the...

  • Mouse models for therapeutic vaccination against hepatitis B virus. Dembek, Claudia; Protzer, Ulrike // Medical Microbiology & Immunology;Feb2015, Vol. 204 Issue 1, p95 

    A mouse model for persistent HBV infection is essential for the development of a therapeutic vaccine against HBV. Because HBV cannot infect mouse hepatocytes, even if the HBV receptor is introduced, surrogate models are used. A suitable model needs to establish persistent HBV replication and...

  • Lung immunity: necessity is the mother of induction. Corbeff, Max; Kraehenbuhl, Jean-Pierre // Nature Medicine;Sep2004, Vol. 10 Issue 9, p904 

    Reports on research concerning respiratory immunity. Examination of lymphoid organogenesis; Formation of lymphoid structures de novo in the lung of mice; Modulation of the immune response by LTα, a member of the TNF family of cytokines.

  • NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner. Glässner, Andreas; Eisenhardt, Marianne; Krämer, Benjamin; Körner, Christian; Coenen, Martin; Sauerbruch, Tilman; Spengler, Ulrich; Nattermann, Jacob // Laboratory Investigation (00236837);Jul2012, Vol. 92 Issue 7, p967 

    In mouse models it has been shown that natural killer (NK) cells can attenuate liver fibrosis via killing of activated hepatic stellate cells (HSCs) in a NKG2D- and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-dependent manner. However, only little data exist regarding...

  • Long-lasting protection in brain trauma by endotoxin preconditioning. Longhi, Luca; Gesuete, Raffaella; Perego, Carlo; Ortolano, Fabrizio; Sacchi, Noemi; Villa, Pia; Stocchetti, Nino; De Simoni, Maria-Grazia // Journal of Cerebral Blood Flow & Metabolism;Sep2011, Vol. 31 Issue 9, p1919 

    We investigated the occurrence of endotoxin (lipopolysaccharide, LPS) preconditioning in traumatic brain injury (TBI), evaluating the time window of LPS-induced protection, its persistence, and the associated molecular mechanisms. Mice received 0.1 mg/kg LPS or saline intraperitoneally and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics